broshy eran  the wall street transcript eran broshy eran broshy joined ventiv health inc as chief executive officer and director in june  shortly before the company’s spinoff from snyder communications and has led ventiv health for the entire time that it has been a publicallytraded company prior to joining ventiv mr broshy served as the partner responsible for the healthcare practice of the boston consulting group bcg across the americas and is a widely recognized authority and frequent speaker on strategic issues in pharmaceuticals and health care during his year tenure at bcg mr broshy consulted widely with senior executives from a number of the major global pharmaceutical manufacturers managed care organizations and academic medical centers and advised on a range of strategic organizational and operational issues mr broshy has also served as president and chief executive officer of coelacanth corporation a privatelyheld biotechnology company he currently also serves as a director of neurogen corporation mr broshy is a graduate of harvard university mba stanford university ms and massachusetts institute of technology bs related interviewseran broshy  ventiv health inc vtivseptember  eran broshy  ventiv health incmarch  eran broshy  ventiv health inc vtivseptember  eran broshy  ventiv health inc vtivaugust  eran broshy  ventiv health inc vtivdecember  eran broshy  ventiv health inc vtivfebruary  eran broshy  ventiv health inc vtivfebruary   cartlatest newsjames abate of centre asset management sees consumer demand driving new stock highsmalcolm e polley of stewart capital and how to play the health care stockstimothy biltz ceo of lumos networks identifies the key component for future g networksthe wall street transcript is a completely unique resource for investors and business researchersover  ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsdelivering longterm results with a riskmanaged growth fundjames a abate published july   in investing strategiescompanies covered amat jnj coh rl cog nvda adbe atvi klac amzn nflx goog fb glw mu  6 wfm jwn cmg gps eqt rice spls buy finding investments with favorable risk and reward opportunitieshenry beukema published july   in investing strategiescompanies covered orcl msft nsrgy amzn wfm lrlcy agn lnr buy better returns and lower risk in the midcap spacemalcolm e polley published july   in investing strategiescompanies covered praa hurn fii fl nke amzn wfm wba rad buy most popular reportswireless communications  telecom published july  buy investing strategies published july  buy investing strategies published june  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsdelivering longterm results with a riskmanaged growth fundfinding investments with favorable risk and reward opportunitiesbetter returns and lower risk in the midcap space analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since 6  the wall street transcript 6 terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google linden capital partners adds operating partner to team  pe hub subscribe to pe hub wire join over  of your peers get the mustread email for pevc professionals delivered to your inbox daily — for free us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions subscribe yes no registersign in a community for professionals in private capital linden capital partners adds operating partner to team march   by angela sormani linden capital partners has added eran broshy as an operating partner broshy joins linden from providence equity partners and will work closely with linden’s team focusing on investments in the provider payer and pharmaceutical services spaces press release linden capital partners a chicagobased private equity firm focused exclusively on healthcare announced today the addition of eran broshy as an operating partner mr broshy joins linden from providence equity partners and will work closely with linden’s team focusing on investments in the provider payer and pharmaceutical services spaces mr broshy has over  years of management experience within the healthcare industry most recently he has been a senior advisor of providence equity partners where he supported the firm’s healthcare information investment efforts previously mr broshy served for over a decade as chief executive officer and chairman of inventiv health nasdaq vtiv mr broshy took the company public in the fall of  and under his leadership transformed the company into the leading provider of commercialization and complementary services to the global pharmaceutical and biotechnology industries growing revenues from  million in  to  billion in 8 mr broshy stepped down as ceo in 8 and as chairman oversaw the company being taken private in  prior to joining inventiv mr broshy served as a partner at the boston consulting group bcg where he was responsible for the firm’s healthcare practice across the americas during his fourteenyear tenure at bcg mr broshy consulted widely with senior executives from a number of the major global pharmaceutical manufacturers managed care organizations and academic medical centers and led a broad range of strategic organizational and operational initiatives mr broshy has also served as president and chief executive officer of coelacanth corporation a privatelyheld biotechnology company mr broshy serves on the board of directors of magellan health services nasdaq mgln and previously has served on the boards of a number of healthcare companies including inventiv coelacanth ikasystems virtual radiologic heartflow and neurogen he is also on the simon wiesenthal center’s ny executive board the mit visiting committee for the social sciences and the mit science dean’s advisory council mr broshy is a graduate of harvard university mba stanford university msc and the massachusetts institute of technology bsc “the broad changes underway across healthcare present myriad opportunities for investment in middle market healthcare services companies and for creating value through the strategic guidance and capital that linden provides” said mr broshy “i was attracted to linden’s exclusive healthcare focus its successful track record of identifying attractive subsectors and platforms and its operating partner model of integrating and leveraging executives across the portfolio at each juncture of the investment cycle from sourcing and diligence to governance throughout the ownership period” “linden is thrilled to add eran to our team of operating executives and continue to expand the resources and support for our portfolio companies” said tony davis a managing partner at linden “eran’s mix of strategic and operating talent depth of experience across a variety of healthcare services sectors and insights from his numerous board roles make him a valuable resource for our investment team and our portfolio companies” about linden capital partners linden capital partners is a chicagobased private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries linden’s strategy is based upon three elements i healthcare and life science industry specialization ii integrated private equity and operating expertise and iii strategic relationships with large corporations linden invests in middle market platforms in the medical products specialty distribution and services segments of healthcare contacts for linden capital partners mark sullivan  6 email protected eran broshy   email protected take your pick buyouts delivers exclusive news and analysis about private equity deals fundraising topquartile managers and more get your free trial or subscribe now vc journal provides exclusive news and analysis about venture capital deals fundraising topquartile investors and more get your free trial or subscribe now sign up to our newsletter receive updates from our pe hub wire and top stories of the week newsletters first name last name email address us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions you are now subscribed to the pehub wire and top stories of the week newsletters buyouts insiderargosy group llc produces several free newsletters that are sent directly to the email you provide at registration namely pe hub wire pe hub canada wire pe hub wire top story of the week buyouts daily and vcj alert to enable us to keep providing these services free of charge we reserve the right to contact you with special invitations to sample or purchase private equityrelated products by submitting this free subscription request for any of these products you are also consenting to this communication should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email this will discontinue both the special invitations mentioned previously as well as your subscription to the weekly newsletter the information you provide will be safeguarded by argosy group llcbuyouts insider the company’s subsidiaries may use it to keep you informed of relevant products and services we occasionally allow reputable companies outside of the company to mail details of products which may be of interest to you as an international group we may transfer your data on a global basis for the purposes indicated above we will never share your email or contact details with any outside company however should you have any questions please do not hesitate to contact us email protected top posts new oil and gas company native racks up  mln by iris dorbian bain capital double impact funds two companies by iris dorbian midocean to sell water pik for  bln by luisa beltran carlyle to invest in zerochaos by luisa beltran awake security nabs over  mln from greylock and bain capital ventures by iris dorbian thoma bravo to sell sparta systems to new mountain by iris dorbian the pe hub podcast episode two by staff report post capital sells bhs specialty chemicals by iris dorbian eran broshy joins providence equity  pe hub subscribe to pe hub wire join over  of your peers get the mustread email for pevc professionals delivered to your inbox daily — for free us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions subscribe yes no registersign in a community for professionals in private capital eran broshy joins providence equity december   by pehub administrator eran broshy has joined providence equity partners as a senior advisor he previously was ceo of inventive health here is his bio from the providence equity website eran broshy is a senior advisor of providence prior to joining providence in  mr broshy served as chief executive officer of inventiv health inc during his tenure at inventiv mr broshy transformed the company into the leading provider of commercialization and complementary services to the global pharmaceutical and biotechnology industries mr broshy remains executive chairman of inventiv prior to joining inventiv mr broshy served as a partner at the boston consulting group where he was responsible for the healthcare practice across the americas mr broshy has also served as president and chief executive officer of coelacanth corporation a privatelyheld biotechnology company mr broshy serves on the boards of magellan health services neurogen corporation and on the simon wiesenthal center’s ny executive board mr broshy received a master of business administration from harvard university a master of science from stanford university and a bachelor of science from the massachusetts institute of technology take your pick buyouts delivers exclusive news and analysis about private equity deals fundraising topquartile managers and more get your free trial or subscribe now vc journal provides exclusive news and analysis about venture capital deals fundraising topquartile investors and more get your free trial or subscribe now sign up to our newsletter receive updates from our pe hub wire and top stories of the week newsletters first name last name email address us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions you are now subscribed to the pehub wire and top stories of the week newsletters buyouts insiderargosy group llc produces several free newsletters that are sent directly to the email you provide at registration namely pe hub wire pe hub canada wire pe hub wire top story of the week buyouts daily and vcj alert to enable us to keep providing these services free of charge we reserve the right to contact you with special invitations to sample or purchase private equityrelated products by submitting this free subscription request for any of these products you are also consenting to this communication should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email this will discontinue both the special invitations mentioned previously as well as your subscription to the weekly newsletter the information you provide will be safeguarded by argosy group llcbuyouts insider the company’s subsidiaries may use it to keep you informed of relevant products and services we occasionally allow reputable companies outside of the company to mail details of products which may be of interest to you as an international group we may transfer your data on a global basis for the purposes indicated above we will never share your email or contact details with any outside company however should you have any questions please do not hesitate to contact us email protected top posts new oil and gas company native racks up  mln by iris dorbian bain capital double impact funds two companies by iris dorbian midocean to sell water pik for  bln by luisa beltran carlyle to invest in zerochaos by luisa beltran awake security nabs over  mln from greylock and bain capital ventures by iris dorbian thoma bravo to sell sparta systems to new mountain by iris dorbian the pe hub podcast episode two by staff report post capital sells bhs specialty chemicals by iris dorbian eran broshy  board of directors  theravance biopharma inc skip to main navigation site map contact us go medicines that make a difference® finding a way eran broshy director eran broshy has served as a director since june  mr broshy is an operating executive with tailwind capital a new york based private equity firm and supports their healthcare investment efforts from march  until august  he worked with linden capital partners and court square capital both private equity firms as operating partner and executive advisor respectively and from june 6 until december  he worked with providence equity partners as a senior advisor supporting the private equity firm’s healthcare information investment efforts mr broshy previously served for over a decade as the chief executive officer until 8 and chairman of the board of directors until  of inventiv health inc a privately held company and until august  a nasdaq listed company that delivers a broad range of clinical and commercialization services to pharmaceutical and life sciences companies globally prior to joining inventiv mr broshy was a management consultant with the boston consulting group “bcg” for  years including as the partner responsible for bcg’s healthcare practice across the americas he also served as president and chief executive officer of coelacanth corporation a privately held biotechnology company he currently serves on the board of directors of magellan health inc a public specialty health care management company he also serves as a member of the corporation of the massachusetts institute of technology “mit” and on mit’s dean of science advisory council as well as the simon wiesenthal center’s new york executive board mr broshy holds an mba from harvard university an ms in civil engineering from stanford university and a bs in civil engineering from the massachusetts institute of technology  member of the audit committeemember of the compensation committee ×   by clicking on the link below you will leave wwwtheravancecom cancel continue eran broshy joins linden as operating partner  pitchbook news log in request a free trial request a free trial log in products products leading data software for vc pe and ma the pitchbook platform pitchbook mobile product overview the pitchbook platform pitchbook mobile app api  data feed crm  excel plugins commitment to service customer success customer testimonials solutions solutions how our clients use the pitchbook platform investment banks venture capital private equity limited partners corporate development lenders law firms accounting firms learn about our platform watch video tutorials data data private company profiles see our data at work research learn more about our process comprehensive data coverage companies investors deals people lps financials funds mergers  aquisitions advisors news  analysis news  analysis industry news  analysis download our latest report sign up for our newsletter private company profiles about about our story press  media center careers at pitchbook our partners event calendar advertise with us contact us news  analysis driven by the pitchbook platform    subscribe private equity venture capital ma more reports videos all report center industry updates in the spotlight blog reports eran broshy joins linden as operating partner march   share linden capital partners a chicagobased private equity firm has hired eran broshy as an operating partner he will work closely with lindens team focusing on investments in the provider payer and pharmaceutical services spaces prior to linden he was a senior advisor with providence equity partners where he supported the firms healthcare information investment efforts he has also served as chairman and ceo of inventiv health a service provider to the pharmaceutical and biotechnology industries and as a partner with the boston consulting group linden focuses exclusively on leveraged buyouts in the healthcare and life science industries eran broshy  operating partner linden capital partners pebuyout chicago il view details share tags private equity venture capital related draftkings fanduel merger just fantasy after all  ways businesses can use private market data to find new clients market insight all business development teams need  predictions about the private markets datagraphic most readshared articles could plenty become agtechs first unicorn  vs  a us pe fundraising throwdown lifting the veil on kkrs succession plan investor spotlight ardian the busiest buyout firm in europe the  most valuable startups in the us trending reports q  us pe breakdown july   q  pitchbooknvca venture monitor july   a better way to do vc pe and ma the pitchbook platform home product solutions data news  analysis about careers contact free trial pitchbook for investment banks venture capital firms private equity firms limited partners corporate development lenders law firms accounting firms our data companies investors deals people lps financials funds ma advisors resources pitchbooknvca partnership video library customer testimonials press inquiries advertise with us get started company profile directory request research request your profile submit a deal subscribe to news  analysis follow us      us headquarters  6 686  fifth avenue suite  seattle wa 86 europe headquarters  8  oliver’s yard  city road london ecy hq united kingdom new york  6 686  fifth avenue suite  new york ny  general inquiries infopitchbookcom   pitchbook data all rights reserved venture capital private equity and ma data and technology provider site map terms of use privacy policy   eranbroshy  fdna objectwppost6   eranbroshy share this page tailwind capital  eran broshy overview straight talk our approach selected investments  our people  eran broshy operating executive mr broshy serves as chairman of the board of directors of dermarite and assists tailwind in sourcing evaluating and performing due diligence and portfolio oversight on healthcare opportunities mr broshy has over  years of management experience within the healthcare industry including serving as chief executive officer and chairman of inventiv health inc for over a decade mr broshy took inventiv public in  and under his leadership transformed the company into the leading provider of clinical and commercialization services to the global pharmaceutical and biotechnology industries growing revenue from  million in  to  billion in 8 in  mr broshy led the companys  billion goprivate transaction subsequent to inventiv health mr broshy partnered with a number of private equity firms to evaluate healthcare investment opportunities prior to inventiv health mr broshy spent  years at the boston consulting group inc bcg where he was responsible for the firms healthcare practice across the americas at bcg mr broshy consulted widely with senior executives from a number of major global pharmaceutical manufacturers managed care organizations and academic medical centers leading solutions on a broad range of strategic organizational and operational initiatives mr broshy also served as president and chief executive officer of coelacanth corporation a privatelyheld biotechnology company mr broshy currently serves as chairman of the board of directors of ert and is on the board of directors of magellan health nasdaq mgln theravance biopharma nasdaq tbph and fdna he previously served on the board of directors of a number of healthcare companies including inventiv health neurogen nasdaq nrgn ikasystems virtual radiologic and heartflow he also serves on the mit corporation board and the mit science deans advisory council mr broshy received an mba from harvard business school an ms from stanford university and a bs from the massachusetts institute of technology national hme see investment detail tailwind capital invests in dermarite learn more   tailwind capital group llc all rights reserved      design by infinia group llc eran broshy  ventiv health inc vtiv  the wall street transcript healthcare  ceo interviews  february   eran broshy – ventiv health inc vtiv eran broshy joined ventiv health inc as chief executive officer and director in june  shortly before the companys spinoff from snyder communications and has led ventiv health for the entire time that it has been a publicallytraded company prior to joining ventiv mr broshy served as the partner responsible for the healthcare practice of the boston consulting group bcg across the americas and is a widely recognized authority and frequent speaker on strategic issues in pharmaceuticals and health care during his year tenure at bcg mr broshy consulted widely with senior executives from a number of the major global pharmaceutical manufacturers managed care organizations and academic medical centers and advised on a range of strategic organizational and operational issues mr broshy has also served as president and chief executive officer of coelacanth corporation a privatelyheld biotechnology company he currently also serves as a director of neurogen corporation mr broshy is a graduate of harvard university mba stanford university ms and massachusetts institute of technology bs profile twst we spoke about a year ago could you give us an update on what hashappened at the company since thenmr broshy there has been a lot of activity weve been moving forwardon join for free to read a longer excerpt or purchase this article already a member login here  cartlatest newsjames abate of centre asset management sees consumer demand driving new stock highsmalcolm e polley of stewart capital and how to play the health care stockstimothy biltz ceo of lumos networks identifies the key component for future g networksthe wall street transcript is a completely unique resource for investors and business researchersover  ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsdelivering longterm results with a riskmanaged growth fundjames a abate published july   in investing strategiescompanies covered amat jnj coh rl cog nvda adbe atvi klac amzn nflx goog fb glw mu  6 wfm jwn cmg gps eqt rice spls buy finding investments with favorable risk and reward opportunitieshenry beukema published july   in investing strategiescompanies covered orcl msft nsrgy amzn wfm lrlcy agn lnr buy better returns and lower risk in the midcap spacemalcolm e polley published july   in investing strategiescompanies covered praa hurn fii fl nke amzn wfm wba rad buy most popular reportswireless communications  telecom published july  buy investing strategies published july  buy investing strategies published june  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsdelivering longterm results with a riskmanaged growth fundfinding investments with favorable risk and reward opportunitiesbetter returns and lower risk in the midcap space analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since 6  the wall street transcript 6 terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google